Longitudinal, cumulative concentration assessment of CXCL10 and IFNγ from a representative human head and neck tumor resection showed an increased production rate with αCD3/αCD28 stimulation for both cross-well and sequential treatment experiments (Fig. 5B). The gene discussed is CXCL10; the disease is head and neck neoplasm.